Medicine and Dentistry
Immunotherapy
100%
Melanoma
100%
Nelfinavir
77%
Elongation Factor 2 Kinase
66%
Transfer Cell
44%
Cytotoxic T-Cell
33%
Antivirus Agent
22%
Tumor Cell
22%
Human Immunodeficiency Virus Infection
11%
Cell Function
11%
Antineoplastic Activity
11%
Clinical Trial
11%
Cancer
11%
In Vitro
11%
Neoplasm
11%
Human Immunodeficiency Virus
11%
Tumor Progression
11%
Protein Synthesis
11%
Cell Death
11%
Kinase
11%
Tumor Immunity
11%
Chimeric Antigen Receptor T-Cell Therapy
11%
Targeted Therapy
11%
T Cell
11%
RNA Translation
11%
Phosphotransferase
11%
Skin Cancer
11%
Messenger RNA
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Immunotherapy
100%
Nelfinavir
77%
Elongation Factor 2 Kinase
66%
Neoplasm
44%
Antivirus Agent
22%
CD8 Antigen
22%
Phosphotransferase
11%
Skin Cancer
11%
HIV
11%
Chemotherapy
11%
Human Immunodeficiency Virus Infection
11%
Clinical Trial
11%
Antitumor Activity
11%
Tumor Growth
11%
Messenger RNA
11%
Diseases
11%
Immunology and Microbiology
Elongation Factor 2
100%
Immunotherapy
100%
Transfer Cell
66%
Cytotoxic T-Cell
33%
Tumor Cell
33%
Human Immunodeficiency Virus Infection
16%
Chimeric Antigen Receptor T-Cell Therapy
16%
Cytotoxic T Cell
16%
RNA Translation
16%
Cell Function
16%
Human Immunodeficiency Virus
16%
Protein Synthesis
16%
Cell Death
16%
Antineoplastic Activity
16%
Tumor Immunity
16%
T Cell
16%